A 100% effective cancer vaccine? Russia’s Enteromix achieves success in trials; Here’s the full report you need to read

Russia's Enteromix vaccine has demonstrated 100% efficacy in preclinical trials, showing promise in fighting tumors. The vaccine, initially targeting colorectal cancer, has shown significant tumor reduction and improved survival rates. Researchers are also developing versions for glioblastoma and melanoma, potentially revolutionizing cancer treatment.